Greenberg Traurig and Quarles & Brady have agreed to fork over a combined $87.5 million to resolve claims that they failed to put the brakes on a $900 million Ponzi scheme carried out by two mortgage-industry clients.

Just in case the class action plaintiffs bar needed another reason to resent the Supreme Court's decision in Wal-Mart v Dukes, they can find it in Tuesday's San Francisco federal court ruling denying certification of a class of more than 1 million black and Hispanic homeowners who were allegedly discriminated against by Wells Fargo.

A federal judge in San Diego certified a statewide consumer class action against Bayer over health claims the company made for its men's multivitamins, rejecting arguments by Bayer's lawyers at DLA Piper that the class claims couldn't survive the Supreme Court's Wal-Mart v. Dukes decision.

What a roller coaster this case has been: After a rare securities class action trial, Barrack Rodos won a huge verdict, only to see it tossed on post-trial motions by Gibson Dunn. Now the Ninth Circuit has concluded that the trial judge erred in finding that shareholder losses didn't result from analyst reports of Apollo's failure to disclose government criticism.

Despite FDA warnings, Hydroxycut has not turned into a bonanza for the personal injury bar. A more serious litigation threat stemmed from a putative class action accusing the manufacturer, Iovate Health Sciences, and retailers who sold the product of violating various states' consumer protection and false advertising laws.